Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011

Journal of Infection and Chemotherapy

Volumn 19, Issue 1, 2013, Pages 34-41

  Ubukata, Kimiko ^a   Chiba, Naoko ^a   Morozumi, Miyuki ^a   Iwata, Satoshi ^b   Sunakawa, Keisuke ^c  

^a KITASATO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Genotypic lactamase nonproducing (gBLNAR); Haemophilus influenzae type b (Hib); Molecular epidemiology; Polymerase chain reaction; Surveillance

Indexed keywords

AMPICILLIN; BETA LACTAM; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTRIAXONE; CEPHEM DERIVATIVE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEROPENEM; PANIPENEM; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD ANALYSIS; BRAIN ATROPHY; BRAIN INFARCTION; CEREBROSPINAL FLUID ANALYSIS; CHILD; COMBINATION CHEMOTHERAPY; DISEASE SURVEILLANCE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CHOICE; GENOTYPE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HEARING DISORDER; HUMAN; INCIDENCE; INFANT; JAPAN; MAJOR CLINICAL STUDY; MORTALITY; MOTOR DYSFUNCTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROGNOSIS; VISUAL DISORDER;

EID: 84874111308     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0448-x     Document Type: Article

References (22)

1. Hasegawa K, Chiba N, Kobayashi R, Murayama SY, Iwata S, Sunakawa K, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in meningitis. Antimicrob Agents Chemother. 2004;48:1509-14.
2. Ishiwada N, Kurosaki T, Terashima I, Ishikawa N, Kaneko K, Kuroki H, et al. The incidence of pediatric Haemophilus influenzae systemic infections. Shounikagaku Zasshi. 2007;111:1568-72 (in Japanese).
3. Hasegawa K, Kobayashi R, Takada E, Ono A, Chiba N, Morozumi M, et al. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother. 2006;57:1077-82.
4. Ubukata K. Problems associated with high prevalence of multi-drug resistant bacteria in patients with community-acquired infections. J Infect Chemother. 2003;9:285-91.
5. Mendelman PM, Chaffin DO, Stull TL, Rubens CE, Mack KD, Smith AL. Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1984;26:235-44.
6. Parr TR Jr, Bryan LE. Mechanism of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus influenzae type b to β-lactam antibiotics. Antimicrob Agents Chemother. 1984;25:747-53.
7. Karlowsky JA, Critchley IA, Blosser-Middleton RS, Karginova EA, Jones ME, Thornsberry C, et al. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strain. J Clin Microbiol. 2002;40:1063-6.
8. Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, Richter SS, Doern GV. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother. 2005;49:2561-4.
9. Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Curr Med Res Opin. 2008;24:2853-61.
10. Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). Antimicrob Agents Chemother. 2010;54:2953-9.
11. Witherden EA, Montgomery J, Henderson B, Tristram SG. Prevalence and genotypic characteristics of β-lactamase-negative ampicillin-resistant Haemophilus influenzae in Australia. J Antimicrob Chemother. 2011;66:1013-5.
12. Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 2001;45:1693-9.
13. Witherden EA, Kunde D, Tristram SG. An evaluation of SNP-based PCR methods for the detection of β-lactamase-negative ampicillin-resistant Haemophilus influenzae. J Infect Chemother. doi: 10.1007/s10156-011-0356-5.
14. Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, et al. Diversity of beta-lactam resistance conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother. 2002;46:2208-18.
15. Skaare D, Allum AG, Anthonisen IL, Jenkins A, Lia A, Strand L, et al. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway. Clin Microbiol Infect. 2010;16:1117-24.
16. Hasegawa K, Yamamoto K, Chiba N, Kobayashi R, Nagai K, Jacobs MR, et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003;9:39-46.
17. Kishii K, Morozumi M, Chiba N, Ono A, Ubukata K. Direct detection by real-time PCR of ftsI gene mutations affecting MICs of β-lactam agents for Haemophilus influenzae isolates from meningitis. J Infect Chemother. 2011;17:671-7.
18. Schoendorf KC, Adams WG, Kiely JL, Wenger JD. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics. 1994;93:663-8.
19. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-6.
20. Centers for Disease Control and Prevention (CDC). Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States, 1987-1997. MMWR Morb Mortal Wkly Rep 1998;47:993-8.
21. Heikki P. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302-17.
22. Sakai F, Hanaki H, Ikeda-Dantsuji Y, Hirao Y, Nonoyama M, Iwata S, et al. Trends in empirical chemotherapy of bacterial meningitis in children aged more than 4 months in Japan: a survey from 1997 through 2008. J Infect Chemother. 2011;17:358-62.